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Clinical Characteristics of Respiratory Syncytial Virus 
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Summary. In an effort to delineate the clinical characteristics of respiratory syncytial virus 
(RSV) infection in the compromised host, we compared children with bronchopulmonary dys- 
plasia (BPD), congenital heart disease (CHD), premature birth, failure to thrive, and gastro- 
esophageal reflux to previously healthy children. During a four-year period, 262 patients were 
admitted to the hospital with RSV infection diagnosed by a rapid RSV antigen detection test. 
Children with BPD or CHD had more hospital days and supplemental oxygen days than the 
previously healthy group (P < 0.05). Patients with BPD also had more ICU days, ventilator days, 
and NPO days, as well as a higher physiologic stability index and therapeutic intervention score 
than the previously healthy group (P < 0.05). Premature infants were more likely to present with 
apnea from RSV (P < 0.001). Patients with underlying illness tended to be older, although 
significant difference was demonstrated only for the BPD group (7.025.3 vs. 3.5e3.3, P < 0.05). 
Patients with BPD and CHD had more nosocomial infections than the previously healthy group 
(P < 0.0001) and death occurred only in patients with underlying illness. We conclude that 
previously compromised patients are at risk for more severe and prolonged RSV disease. Earlier 
diagnosis and therapeutic intervention may be necessary in such patients to improve outcome. 
Pediatr Pulmonol. 1989; 7:167-170. 
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INTRODUCTION 
Respiratory syncytial virus (RSV) infection occurs in 
yearly outbreaks and is a major cause of upper and lower 
respiratory tract disease in young children. Between 5% 
and 40% of pneumonias and 60-90% of bronchiolitis in 
young children are caused by RSV, and virtually all chil- 
dren will have had at least one RSV infection by three 
years of age.’ The readily available rapid laboratory 
identification of the virus has helped understanding the 
epidemiology and mode of transmission of RSV disease. 
Significant morbidity and mortality have been attributed 
to RSV, particularly in children with previous cardiopul- 
monary The purpose of this study was to 
evaluate the relationship between the previous state of 
health and the clinical characteristics of RSV disease in 
hospitalized children. 
MATERIALS AND METHODS 
The medical records of all patients hospitalized at 
Children’s Hospital of Michigan with RSV infection for 
the four-year period between 1985 and 1988 were re- 
viewed. The diagnosis was established by rapid RSV 
antigen detection test on nasal washings (Kallestad Path- 
finder-Respiratory Syncytial Virus Direct Detection Sys- 
tem). Nasal washings were obtained by the previously 
described technique of instilling sterile saline into the 
child’s nares followed by suctioning with a rubber bulb 
~ y r i n g e . ~  Patients were allocated to one of the following 
six study groups based on their primary underlying di- 
agnosis: 1) previously healthy group (HG) with no un- 
derlying medical problems; 2) history of bronchopulmo- 
nary dysplasia (BPD); 3) congenital heart disease 
(CHD); 4) prematurely born infants (PREM), with ges- 
tational age 5 37 weeks, and no BPD or CHD; 5 )  failure 
to thrive (FTT) with body weight less than the fifth per- 
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centile for age; and 6) gastroesophageal reflux (GER) 
demonstrated on either nuclear scintiscan or esophageal 
pH determination. 
Dependent variables measured included the age, num- 
ber of hospital days, intensive care unit (ICU) days, ven- 
tilator days, supplemental oxygen days, NPO days, ap- 
nea at presentation, physiologic stability index (PSI) ,6 
therapeutic intervention score (TISS) ,7 nosocomial infec- 
tions, mortality, ribavirin use, and blood culture results. 
For patients on home oxygen therapy, supplemental ox- 
ygen days were defined as days when oxygen require- 
ments were higher than the baseline home requirements. 
Apnea was defined as absence of respirations for longer 
than 15 seconds in hospital-observed cases or as absence 
of respirations associated with cyanosis in cases ob- 
served by a lay person prior to hospitalization. PSI is an 
established scoring system consisting of 34 variables 
from seven physiologic systems in which the degree of 
abnormality of each variable is assigned a standard score 
reflecting the clinical severity of the derangement. TISS 
consists of approximately 70 variables representing var- 
ious therapeutic interventions each of which is assigned 
a standard score based on complexity and invasiveness of 
the therapy. Higher PSI scores indicate a greater degree 
of physiologic instability while higher TISS scores indi- 
cate more therapeutic intervention. The highest 24-hour 
scores for each patient were recorded. Nosocomial RSV 
infections were defined as those occurring in a previ- 
ously uninfected child who had been hospitalized for 
more than seven days.' Due to the retrospective nature of 
this study documentation of criteria for use of supple- 
mental oxygen, ribavirin therapy, and the need for NPO 
could not be obtained and may have differed among the 
various clinical services caring for these patients. Me- 
chanical ventilation was initiated for apnea, respiratory 
acidosis (pH < 7 . 2 3 ,  hypoxemia (capillary PO2 less 
than 50 mm Hg at Fi02 of 60%), or clinical impression 
of fatigue. 
Statistical analysis was performed using chi-square 
test for nominal dependent variables and one-way anal- 
ysis of variance followed by Tukey's Honestly Signifi- 
cant Difference test for discrete and continuous depen- 
dent variables. 
RESULTS 
During the four-year study period 262 patients were 
hospitalized with RSV infection. Of these, 19 had BPD, 
13 had CHD, 56 were prematurely born without BPD or 
CHD, 8 had ITT,  4 had GER, and 161 had been previ- 
ously healthy. Individual congenital heart lesions are 
summarized in Table 1.  One additional patient with 
asymptomatic human immunodeficiency virus infection 
acquired RSV-related upper respiratory tract illness in 
the hospital while awaiting foster care. 
TABLE 1-Types of Congenital Heart Disease 
Lesion No. of patients 
Atrial septal defect 3 
Ventricular septal defect 2 
Atrial and ventricular septal defects 3 
Atrioventricular canal 2 
Hypoplastic right heart, pulmonary atresia 2 
Mitrial regurgitation, left atrial aneurism 1 
Total 13 
The clinical characteristics of the hospital course in the 
various groups are described in Table 2. Because hospi- 
talized patients are expected to be sicker than non-hos- 
pitalized patients, patients with nosocomial RSV infec- 
tions (n = 12) were excluded from the analysis. Children 
with BPD were found to have significantly more hospital 
days, ICU days, ventilator days, supplemental oxygen 
days, and NPO days as well as a greater degree of phys- 
iologic instability and need for therapeutic intervention, 
than the HG (P  < 0.05). The CHD group had more 
hospital days and supplemental oxygen days than HG (P 
< 0.05). CHD patients also tended to have higher al- 
though not statistically different PSI and TISS scores. 
The PREM group had more hospital days and higher PSI 
scores (P  < 0.05). The FTT and GER groups did not 
differ from each other or from the HG in any of the above 
mentioned variables. Patients with pre-existing illness 
tended to be older than HG infants, although a significant 
difference was demonstrated only for those with BPD 
(7.0k5.3 months vs. 3 .523.3 months, P < 0.05). Table 
3 shows the proportion of patients in each group, exclud- 
ing nosocomially acquired cases of RSV, requiring ICU 
admission, supplemental oxygen, mechanical ventila- 
tion, and NPO status. 
Blood cultures were obtained in 129 patients during 
their RSV illness with only two yielding bacterial patho- 
gens. One patient with CHD had enterococcal and one 
PREM had pneumococcal bacteremia. 
The incidence of apnea as a presenting symptom, of 
the use of ribavirin, and of nosocomial infection are de- 
scribed in Table 4. Apnea occurred in 10% (26/262) of 
all patients. Patients with PREM (1 1/56) and BPD (5/19) 
were more likely to have apnea as the initial manifesta- 
tion of their RSV illness than the HG (7/161), X2 = 
17.5, P < 0.001. Ribavirin therapy was employed in 
13% (34/262) of all patients and most frequently (54%; 
7/13) in those with CHD. RSV was nosocomially ac- 
quired in 5% (12/262) of all patients. More patients with 
BPD (4/19) and CHD (3/13) acquired nosocomial infec- 
tion than HG patients (1/161), X2=35.4,  P<O.OOOl). 
There were three deaths-two in the BPD and one in the 
CHD group. All deaths occurred because of severe, in- 
tractable hypoxia. Two of the three deaths resulted 
from nosocomial infection. 
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TABLE 2-Clinical Characteristics of RSV Infectiona 
Hospital Ventilator Supplemental 
Age (mas) total days ICU days days O2 days NPO days PSI TISS 
BPD 7.0 t 5.3* 11.3 t 9.4* 3.9 t 7.8* 3.5 f 7.9* 7.4 f 9.9* 3.2 t 5.8* 10.3 f 11.1* 16.7 t 19.6* 
CHD 6.3 t 6.0 9.1 t 3.6* 1.5 t 2.3 0.2 f 0.6 5.0 t 4.9* 1.3 t 1.9 7.7 f 7.4 11.9 f 8.9 
PREM 4.8 t 5.8 5.7 t 3.4* 0.9 t 2.1 0.7 f 1.5 2.3 lr 3.4 0.7 t 1.7 6.5 k 5.9* 8.2 t 6.5 
FIT 6.8 f 2.8 4.1 t 1.7 0.0 t 0.0 0.0 f 0.0 0.0 f 0.0 0.0 t 0.0 2.1 2 1.6 4.1 t 2.3 
GER 2.8 f 1.5 4.3 f 2.5 0.0 t 0.0 0.0 t 0.0 0.0 k 0.0 0.0 f 0.0 3.0 t 2.6 3.7 t 0.6 
HG 3.5f3.3 4.1k2.5 0.2f1.5 O.ltl.O 0.9t2.1 0.3t1.1 4.1t3.9 5.7 t 4.5 
F 3.9 14.6 6.3 7.0 12.7 7.1 6.0 8.6 
P <0.005 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
"All values in mean f SD. F and P values for one way analysis of variance across groups; all six groups compared to each other. 
*Significantly different from HG at 0.05 level by Tukey's Honestly Significant Difference Test. 
<0.0001 
TABLE +Number of Patients in Various Groups 
Requiring ICU Admission, Mechanical Ventilation, 
Supplemental Oxygen, and NPO Statusa 
ICU Mechanical Supplemental 
admission ventilation oxygen 
BPD 5/15 4/15 8/15 
CHD 41 1 Ob 1/10 6/10 
PREM 12/55 1 1/55b 24/59 
HG 10/160 51160 321160 
X2 22.4 21.2 21.1 









"FIT and GER groups not included in chi square analysis because of 
small sample size. 
bMajor component to chi square. 
DISCUSSION 
Children with CHD have been reported to develop 
severe illness with RSV infection. Our findings indicate 
that infants with BPD are also more susceptible to severe 
and prolonged illness from RSV than otherwise healthy 
children. The increased severity of illness is more likely 
to be due to additional cardiopulmonary compromise 
from RSV infection itself, rather than to secondary 
bacterial infections. The latter appears to be a rare 
complication of RSV infection even in the compromised 
host, as only two such patients were found to be 
bacteremic . Children with underlying cardiopulmonary 
illness, especially those with pulmonary hypertension, 
are particularly vulnerable to develop fatal RSV in- 
fection. 1,2 The overall mortality in the present study 
(1%) is lower than in other reported series, although all 
three deaths occurred in patients with pre-existing 
illness. Premature infants had a greater degree of 
physiologic instability, requiring more hospital days 
than HG. Also, the proportion of premature infants 
(56/262, 21%) was higher than expected from the 
observed prevalence of prematurity in the general 
population. Premature birth may therefore be an 
important risk factor for developing RSV infection of 
sufficient severity to require hospitalization. 
Apnea is a known complication of RSV infection al- 
TABLE &Number of Patients in Various Groups With 
ADnea. Ribavirin. and Nosocomial Infectiona 
ADnea Ribavirin therauv Nosocomial infection 
BPD 5/19b 5/19 4/19b 
CHD 2/13 7/13b 3/13b 
PREM 11/56b 10156 1/56 
HG 71161 12/16] 11161 
X2 17.5 26.2 35.4 
P <0.001 <0.001 <0.0001 
aFTT and GER groups not included in chi square analysis because of 
small sample size. 
bMajor component to chi square. 
though the mechanism is unclear. It has been described 
as a form of central apnea, characterized by a lack of 
respiratory effort leading to cessation of ventilation.' 
RSV-associated apnea has been reported to be most fre- 
quent during the first month of life and in premature 
infants, particularly if there is a history of apnea during 
the neonatal period.','0 Our results indicate that prema- 
turely born infants with or without BPD are at risk for 
apnea as a presenting feature of RSV infection. 
The peak incidence of RSV infection necessitating 
hospitalization is two to five months of age." However, 
children with BPD may develop severe pulmonary 
compromise from RSV disease even at an older age. 
RSV should therefore be considered as a possible 
etiology of respiratory decompensation in BPD patients 
at any age. In this study population, CHD patients also 
tended to be at risk of developing RSV disease at an 
older age. 
Nosocomial RSV infections are common. The risk of 
acquiring RSV while hospitalized during a community 
epidemic is high and proportional to the length of stay.* 
We have demonstrated that nosocomial RSV infection is 
an important hazard for patients with BPD and CHD. 
The risks and benefits of elective admissions for BPD 
and CHD patients should therefore be carefully weighed 
during RSV epidemics. Protective isolation of such pa- 
tients may decrease morbidity. 
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